Brief: Karolinska Development Invests SEK 7.5 Million In Boost Pharma
28/10/2025 10:10
Oct 28 (Reuters) - Karolinska Development AB KDEV.ST: REG-KAROLINSKA DEVELOPMENT INVESTS SEK 7.5 MILLION TO SUPPORT BOOST PHARMA’S CONTINUED DEVELOPMENT OF BT-101 TOWARDS PHASE 3 Source text: ID:nGNESZ9lt Further company coverage: KDEV.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Kdventures AB
See all newsRefile: BRIEF-Umecrine Cognition Gets Notice Of Allowance In US
Brief: KDventures' Modus Therapeutics Pauses Enrollment In Phase 2A Study
Brief: KDventures' AnaCardio Raises €62.5 Million
Brief: Kdventures' Umecrine Cognition Gets Two USPTO Notices Of Allowance For Patent Applications
Brief: Kdventures' Modus Therapeutics Carries Out Directed Issue